138 related articles for article (PubMed ID: 15681940)
1. A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass.
Avidan MS; Levy JH; Scholz J; Delphin E; Rosseel PM; Howie MB; Gratz I; Bush CR; Skubas N; Aldea GS; Licina M; Bonfiglio LJ; Kajdasz DK; Ott E; Despotis GJ
Anesthesiology; 2005 Feb; 102(2):276-84. PubMed ID: 15681940
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass.
Avidan MS; Levy JH; van Aken H; Feneck RO; Latimer RD; Ott E; Martin E; Birnbaum DE; Bonfiglio LJ; Kajdasz DK; Despotis GJ
J Thorac Cardiovasc Surg; 2005 Jul; 130(1):107-13. PubMed ID: 15999048
[TBL] [Abstract][Full Text] [Related]
3. Management of Heparin-Resistant Patients with Benefits? Maximizing Biocompatibility in Cardiopulmonary Bypass: Combining ATryn® Recombinant Antithrombin III and Carmeda® Heparin-Bonded Perfusion Circuits: A Case Series.
Chryssos A; Stroup SJ; Pifer MM; Tawil M; Conrad CG
J Extra Corpor Technol; 2015 Mar; 47(1):44-7. PubMed ID: 26390679
[TBL] [Abstract][Full Text] [Related]
4. Is there evidence that fresh frozen plasma is superior to antithrombin administration to treat heparin resistance in cardiac surgery?
Beattie GW; Jeffrey RR
Interact Cardiovasc Thorac Surg; 2014 Jan; 18(1):117-20. PubMed ID: 24014620
[TBL] [Abstract][Full Text] [Related]
5. Influence of high-dose aprotinin on anticoagulation, heparin requirement, and celite- and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery. A double-blind, placebo-controlled study.
Dietrich W; Dilthey G; Spannagl M; Jochum M; Braun SL; Richter JA
Anesthesiology; 1995 Oct; 83(4):679-89; discussion 29A-30A. PubMed ID: 7574046
[TBL] [Abstract][Full Text] [Related]
6. Decreased concentration of antithrombin after preoperative therapeutic heparin does not cause heparin resistance during cardiopulmonary bypass.
Linden MD; Schneider M; Baker S; Erber WN
J Cardiothorac Vasc Anesth; 2004 Apr; 18(2):131-5. PubMed ID: 15073698
[TBL] [Abstract][Full Text] [Related]
7. Treating heparin resistance with antithrombin or fresh frozen plasma.
Spiess BD
Ann Thorac Surg; 2008 Jun; 85(6):2153-60. PubMed ID: 18498854
[TBL] [Abstract][Full Text] [Related]
8. Transgenic antithrombin III (Genzyme).
Yeung PK
IDrugs; 2000 Jun; 3(6):669-73. PubMed ID: 16096931
[TBL] [Abstract][Full Text] [Related]
9. Antithrombin III concentrate to treat heparin resistance in patients undergoing cardiac surgery.
Lemmer JH; Despotis GJ
J Thorac Cardiovasc Surg; 2002 Feb; 123(2):213-7. PubMed ID: 11828278
[TBL] [Abstract][Full Text] [Related]
10. The in vitro effects of antithrombin III on the activated coagulation time in patients on heparin therapy.
Levy JH; Montes F; Szlam F; Hillyer CD
Anesth Analg; 2000 May; 90(5):1076-9. PubMed ID: 10781455
[TBL] [Abstract][Full Text] [Related]
11. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
[TBL] [Abstract][Full Text] [Related]
12. Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity.
Manlhiot C; Gruenwald CE; Holtby HM; Brandão LR; Chan AK; Van Arsdell GS; McCrindle BW
J Thorac Cardiovasc Surg; 2016 Feb; 151(2):444-50. PubMed ID: 26553458
[TBL] [Abstract][Full Text] [Related]
13. Increased anticoagulation during cardiopulmonary bypass by aprotinin.
de Smet AA; Joen MC; van Oeveren W; Roozendaal KJ; Harder MP; Eijsman L; Wildevuur CR
J Thorac Cardiovasc Surg; 1990 Oct; 100(4):520-7. PubMed ID: 1699088
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human transgenic antithrombin in cardiac surgery: a dose-finding study.
Levy JH; Despotis GJ; Szlam F; Olson P; Meeker D; Weisinger A
Anesthesiology; 2002 May; 96(5):1095-102. PubMed ID: 11981148
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: a randomized, placebo-controlled, multicenter clinical trial.
Karkouti K; von Heymann C; Jespersen CM; Korte W; Levy JH; Ranucci M; Sellke FW; Song HK
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):927-39. PubMed ID: 23820174
[TBL] [Abstract][Full Text] [Related]
16. Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass?
Brinks HJ; Weerwind PW; Bogdan S; Verbruggen H; Brouwer MH
Perfusion; 2001 Jan; 16(1):3-12. PubMed ID: 11192305
[TBL] [Abstract][Full Text] [Related]
17. Completely heparinized cardiopulmonary bypass and reduced systemic heparin: clinical and hemostatic effects.
Ovrum E; Holen EA; Tangen G; Brosstad F; Abdelnoor M; Ringdal MA; Oystese R; Istad R
Ann Thorac Surg; 1995 Aug; 60(2):365-71. PubMed ID: 7646097
[TBL] [Abstract][Full Text] [Related]
18. Double-Blind, Randomized, Placebo-Controlled Trial Comparing the Effects of Antithrombin Versus Placebo on the Coagulation System in Infants with Low Antithrombin Undergoing Congenital Cardiac Surgery.
Jooste EH; Scholl R; Wu YH; Jaquiss RDB; Lodge AJ; Ames WA; Homi HM; Machovec KA; Greene NH; Donahue BS; Shah N; Benkwitz C
J Cardiothorac Vasc Anesth; 2019 Feb; 33(2):396-402. PubMed ID: 30072263
[TBL] [Abstract][Full Text] [Related]
19. [The effect of antithrombin iii concentrations during cardiopulmonary surgery].
Sonzogni V; Bellavita P; Carrara B; Cossolini M; Ferri F; Fabretti F; Mamprin F; Pelliccioli I
Minerva Anestesiol; 2000; 66(1-2):17-23. PubMed ID: 10736978
[TBL] [Abstract][Full Text] [Related]
20. Effect of antithrombin in fresh frozen plasma on hemostasis after cardiopulmonary bypass surgery.
Shirozu K; Karashima Y; Yamaura K
Perfusion; 2021 May; 36(4):395-400. PubMed ID: 32781884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
